SCHEMBL6164796

SCHEMBL6164796

COc1cccc(-c2nn(CCO)c3c2C(=O)CC3)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.43
KCNK3 O14649 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPK1 P28482 2/20 0.42
BRD4 O60885 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.42
PTGIR P43119 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.39
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
RECQL P46063 1/20 0.38
RIPK2 O43353 1/20 0.38
GAA P10253 2/20 0.38
HDAC4 P56524 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
NR1H2 P55055 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164169 0.82 HTT (0.48) HTTKMT2AHSD17B10PTGIRSMN1; SMN2
SCHEMBL6162358 0.81 HTT (0.46) HTTKMT2AALDH1A1MAPTGAA
SCHEMBL6166822 0.71 HTT (0.44) HTTKMT2ABRD4ALDH1A1MAPT
SCHEMBL6166715 0.69 KCNK3 (0.39) HTTKCNK3KMT2AMAPK1BRD4
SCHEMBL6167324 0.69 BRD4 (0.38) HTTKCNK3KMT2AMAPK1BRD4
SCHEMBL11166069 0.67 L3MBTL1 (0.46) KMT2AMAPK1SMN1; SMN2LMNAALDH1A1
SCHEMBL6164117 0.65 HTT (0.46) HTTKMT2ATSHRLMNAMAPT
SCHEMBL16193457 0.64 BRD4 (0.48) KMT2AMAPK1BRD4LMNANPC1
SCHEMBL3937799 0.64 KMT2A (0.63) HTTKMT2APTGIRSMN1; SMN2ALDH1A1
SCHEMBL7480329 0.64 HRH2 (0.46) HTTKMT2AMAPK1BRD4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed